主动脉血管支架市场：2026-2032年全球市场预测（依动脉瘤部位、移植物类型、结构、植入机制、最终用户、入路和材料划分）

预计到 2025 年，主动脉血管支架市场价值将达到 11.3 亿美元，到 2026 年将成长至 12.1 亿美元，到 2032 年将达到 17.8 亿美元，复合年增长率为 6.62%。

主要市场统计数据
基准年 2025	11.3亿美元
预计年份：2026年	12.1亿美元
预测年份 2032	17.8亿美元
复合年增长率 (%)	6.62%

对当前主动脉血管支架生态系统以及医疗技术领导者和临床相关人员应指南的策略挑战进行权威概述。

主动脉血管支架领域正处于一个关键的十字路口，医疗设备技术的进步、临床实践模式的改变以及对成本和治疗结果日益严格的监测交织在一起。临床医生越来越倾向于采用微创血管内治疗来治疗各种主动脉疾病，而器械开发商则致力于平台创新，以提高支架的贴合度、闭塞效果和分支血管的保护。同时，医院和门诊手术中心正在重新审视其采购系统，以在手术数量和可持续的临床疗效之间取得平衡。

主动脉治疗领域正在发生变革性变化，重塑临床实务、产品设计和经营模式。

主动脉血管支架领域正受到多种趋势的共同影响，这些趋势正在改变器械的设计、评估和应用方式。首先，器械结构正朝着更贴合解剖结构的方向发展，采用更复杂的分支和开窗结构的解决方案能够治疗以往被认为无法手术的解剖结构。同时，输送系统的进步也促进了这一趋势，提高了操作便利性并缩小了器械体积，从而扩大了目标患者群体的手术适应症范围。此外，长期临床数据和真实世界证据的积累，也增强了血管内修復提案相对于开放性手术某些类型动脉瘤的价值，从而推动了一种优先选择微创治疗方案的治疗策略，前提是治疗效果和手术入路允许。

近期美国关税措施对临床供应链和製造商策略的累积影响。

近期针对医疗设备零件和成品的关税措施为器械製造商和医疗系统带来了新的成本和营运挑战。由于关税导致投入成本增加，製造商正在重新思考筹资策略，将生产重心转移到贸易环境更稳定的地区，或透过供应商多元化来规避关税波动风险。这种调整影响了前置作业时间、库存水准和供应商认证进度，对短期供应连续性构成压力，并要求采购团队采取积极主动的措施。

基于解剖结构、器材、手术和最终用户细分的关键细分见解，以製定临床和商业策略。

主动脉血管支架市场根据几个具有重要临床意义的因素进行细分，这些因素影响产品需求和市场进入策略。动脉瘤的位置是主要决定因素，可分为腹部主动脉血管瘤主动脉瘤、胸主动脉瘤和腹部主动脉血管瘤。每种解剖亚型在入路、封锁和分支血管保护方面都面临不同的挑战。在这些类别中，临床紧急程度区分了规划手术和急诊手术，从而影响器械库存需求、商店供应以及快速部署培训的需求。

影响全球主要市场差异化商业化和临床导入策略的区域趋势

区域趋势影响着科技的采纳、监管和采购，因此需要製定在地化的策略。在美洲，临床证据与报销方案的一致性备受重视，医院和病患量大的医疗中心往往是复杂分支和开放式诊疗系统的早期采用者。相较之下，欧洲、中东和非洲（EMEA）地区的技术采纳率参差不齐，这主要是由于各国采购通讯协定、报销环境的波动以及医院基础设施的巨大差异。这些因素共同导致部分地区的技术采纳较为先进，而其他地区则因成本和准入限製而发展受限。

深入分析竞争格局，重点放在医疗设备製造商与生态系统合作伙伴之间的策略行动、能力差距和合作机会。

主要企业继续透过结合技术差异化、临床证据和服务水准保证来展开竞争。产品蓝图日益强调模组化和解剖结构定制，以应对复杂的解剖结构，而其他製造商则专注于低调的输送系统和简化的部署，以适应频繁的选择性手术项目。策略性倡议包括有针对性的收购，以弥补分支和开窗技术领域的能力缺口，以及旨在加速专业解决方案上市的授权和共同开发契约。

产业领导者可以实施的实用建议，以增强韧性、加速推广应用并最大限度地发挥临床影响。

製造商应优先考虑模组化产品平台，以提高生产效率和库存管理水平，同时应对各种不同的解剖结构挑战。投资于产生全面的临床证据，包括前瞻性註册研究和可操作的真实世界研究，可以增强对医院和保险公司的价值提案，并降低产品推广的门槛。在营运方面，关键零件供应商多元化，并探索本地製造和契约製造伙伴关係，可以提高对本地需求的应对力，同时降低关税和物流风险。

用于评估主动脉血管支架临床、商业性和监管方面的调查方法和证据整合方法。

本分析采用混合研究设计，整合了原始质性资料和全面的二手资讯。原始研究部分，我们对临床医生、医院采购经理和医疗设备研发专家进行了结构化访谈，以了解临床实践模式、器材选择标准和采购考量。我们将这些定性研究结果与二手资讯进行交叉比对，包括同行评审的临床文献、已发布的监管附加檔、临床试验註册资讯和医疗指南，以检验技术声明和临床性能说明。

结论整合了对临床、商业和营运领域相关人员的策略意义。

主动脉血管支架领域正迈入一个新阶段，在这个阶段，技术复杂性、对实证医学的需求以及供应链的韧性三者将共同决定竞争优势。成功的关键在于提供既能满足日益复杂的解剖学要求，又能同时展现临床疗效和成本效益的器材。那些将研发进展与严谨的实证医学体系和稳健的营运策略结合的机构，将更有能力满足临床医师的期望和采购需求。

目录

第一章：序言

第二章：调查方法

• 调查设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查的前提
• 研究限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 市场进入策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会映射
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按动脉瘤部位分類的主动脉血管支架市场

• 腹部主动脉血管瘤
• 胸主动脉瘤
• 胸腹腹部主动脉血管瘤

第九章：主动脉血管支架市场（依移植物类型划分）

• 分支支架血管支架
• 开窗型血管支架
• 标准血管支架

第十章：主动脉血管支架市场：依组成

• 主动脉 - 单侧髂动脉
• 分支类型
• 袖口

第十一章 主动脉血管支架市场（依植入方法划分）

• 球囊扩张型
• 自膨胀

第十二章 主动脉血管支架市场：依最终用户划分

• 门诊手术中心
• 医院

第十三章：主动脉血管支架市场进入路渠道划分）

• 髂骨
• 经股动脉

第十四章 主动脉血管支架市场：依材料分类

• 膨体聚四氟乙烯
• 聚酯纤维

第十五章 主动脉血管支架市场：依地区划分

• 北美洲和南美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十六章 主动脉血管支架市场：依组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十七章 主动脉血管支架市场：依国家划分

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章：美国主动脉血管支架市场

第十九章：中国主动脉血管支架市场

第20章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Abbott Laboratories
• Aortec Medical Technology Co., Ltd
• Aptus Endosystems, Inc.
• Artivion, Inc.
• Becton, Dickinson and Company
• Bentley InnoMed GmbH
• Bolton Medical Inc.
• Cardinal Health, Inc.
• Cook Medical LLC
• CryoLife, Inc.
• Endologix, Inc.
• Endospan Ltd
• JOTEC GmbH
• LifeTech Scientific Co., Ltd
• Lombard Medical Ltd
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Terumo Corporation
• WL Gore & Associates, Inc.

The Aortic Stent Grafts Market was valued at USD 1.13 billion in 2025 and is projected to grow to USD 1.21 billion in 2026, with a CAGR of 6.62%, reaching USD 1.78 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 1.13 billion
Estimated Year [2026]	USD 1.21 billion
Forecast Year [2032]	USD 1.78 billion
CAGR (%)	6.62%

An authoritative orientation to the current aortic stent graft ecosystem and the strategic imperatives that should guide medtech leaders and clinical stakeholders

The aortic stent graft sector occupies a critical juncture at the intersection of advancing device technology, shifting clinical practice patterns, and heightened scrutiny on cost and outcomes. Clinicians increasingly favor minimally invasive endovascular therapies for a broadening set of aortic pathologies, while device developers pursue platform innovations that improve conformability, seal, and branch vessel preservation. At the same time, hospitals and ambulatory surgical centers are recalibrating procurement frameworks to balance procedural throughput with durable clinical results.

This introduction frames the principal forces shaping product development, clinical adoption, and commercial strategy. It synthesizes recent regulatory milestones, emergent clinical evidence, and supply chain considerations that now inform go-to-market decisions. Readers will gain an actionable orientation to the priority challenges and opportunities facing manufacturers, providers, and payers, enabling clearer alignment of R&D, commercial, and policy objectives as they plan for the short and medium term.

In the sections that follow, the report distills structural shifts across technology, reimbursement environments, and geography, then translates those observations into segmentation, regional, and competitive insights designed to inform investment and product strategy decisions.

Transformative shifts reshaping clinical practice, product design, and commercial models in aortic therapeutics

The landscape of aortic stent grafts is being reshaped by several convergent trends that alter how devices are designed, evaluated, and adopted. First, device architectures are moving toward greater anatomic customization, with more complex branched and fenestrated solutions enabling treatment of previously inoperable anatomies. This trend is complemented by advances in delivery systems that improve navigability and lower profile, which together expand the procedural candidacy across patient cohorts. Simultaneously, the accumulation of long-term clinical data and real-world evidence has strengthened the value proposition of endovascular repair versus open surgery for selected aneurysm types, prompting care pathways to prioritize minimally invasive options where outcomes and access permit.

On the commercial front, procurement strategies are becoming more value-driven; hospitals and ambulatory surgical centers increasingly require evidence of cost-effectiveness, device longevity, and post-market surveillance commitments. This has elevated the importance of lifecycle data and post-approval studies, encouraging manufacturers to invest in registries and partnerships with clinical centers. Supply chain resilience has also become a strategic priority, with manufacturers reassessing supplier concentration, dual sourcing critical components, and exploring regional manufacturing footprints to mitigate disruption risks. Collectively, these shifts are driving a more integrated approach to innovation, where clinical evidence generation, manufacturing robustness, and commercial alignment are no longer sequential priorities but simultaneous imperatives.

Cumulative impact of recent United States tariff actions on clinical supply chains and manufacturer strategies

Recent tariff actions affecting medical device components and finished products have introduced new cost and operational dynamics for device manufacturers and health systems. Tariff-induced increases in input costs have prompted manufacturers to reassess sourcing strategies, shifting production emphasis toward regions with more predictable trade terms or to diversify suppliers to hedge against tariff volatility. This reconfiguration has implications for lead times, inventory carrying, and supplier qualification timelines, creating near-term pressures on supply continuity that require proactive mitigation by procurement teams.

Clinicians and hospital administrators have felt the downstream effects through tighter negotiation cycles and heightened scrutiny of total procedure costs. In response, some manufacturers have pursued margin protection strategies that include selective regional pricing adjustments, renegotiated supplier contracts, and targeted product bundling that rationalizes inventory. At the same time, providers have accelerated efforts to validate suppliers' long-term commitments to service levels and warranty performance, since supply disruptions can threaten elective procedure scheduling.

Regulatory and compliance teams are adapting to tariff-related documentation and classification challenges, which can slow customs clearance and add administrative overhead. To manage these effects, forward-looking organizations are investing in scenario planning, flexible manufacturing arrangements, and closer collaboration between commercial strategy and operations to preserve clinical access while navigating the shifting trade landscape.

Key segmentation insights drawing on anatomic, device, procedural, and end-user distinctions that structure clinical and commercial strategy

The market for aortic stent grafts fragments along multiple clinically meaningful dimensions that shape product requirements and go-to-market strategies. Aneurysm location is a primary determinant, separating abdominal aortic aneurysm from thoracic aortic aneurysm and thoracoabdominal aortic aneurysm, with each anatomic subset presenting distinct access, sealing, and branch preservation challenges. Within these categories, the clinical urgency differentiates elective repair cases from emergency repair scenarios, influencing device inventory needs, on-shelf availability, and training imperatives for rapid deployment.

Graft type drives technical differentiation and clinical value, with branched stent grafts and fenestrated stent grafts tailored to complex, branch-involving anatomies, while standard stent grafts address more straightforward profiles and often prioritize ease of delivery. Configuration nuances such as aorto-uni-iliac, bifurcated, and cuff designs determine fixation mechanics and compatibility with adjunctive devices, shaping both procedure planning and post-procedural surveillance. Deployment mechanics separate balloon expandable systems from self expanding platforms, each conferring trade-offs in radial force, conformability, and delivery sheath size that affect case selection and operator preference.

End-user setting exerts a profound influence on procurement cycles and support models, as ambulatory surgical centers prioritize throughput and device simplicity, whereas hospitals manage a broader mix of elective and emergency volumes requiring diverse inventory. Access route choices, notably iliac versus transfemoral approaches, steer product profile requirements and anatomical constraints. Finally, material selection such as expanded polytetrafluoroethylene versus polyester fabrics impacts long-term durability, thrombogenicity considerations, and regulatory dossier composition. Taken together, these segmentation axes demand that manufacturers align portfolio breadth with clinical training programs and targeted evidence to support adoption across heterogeneous care settings.

Regional dynamics that inform differentiated commercialization and clinical adoption approaches across major global markets

Regional dynamics shape how technologies are adopted, regulated, and purchased, requiring tailored strategies for each geography. The Americas market exhibits a strong emphasis on clinical evidence and reimbursement alignment, with hospitals and high-volume centers often acting as early adopters for complex branched and fenestrated systems. In contrast, Europe, Middle East & Africa displays heterogeneous adoption rates driven by national procurement protocols, variable reimbursement environments, and widely differing hospital infrastructures, which together create both pockets of advanced uptake and regions where cost and access constraints limit penetration.

Asia-Pacific markets present a diverse set of opportunities, where rapid hospital expansion and increasing investment in minimally invasive surgery are driving demand for a wider array of device configurations, yet local regulatory pathways and preferences for cost-competitive solutions shape purchasing choices. Across all regions, logistical considerations such as customs processes, regional distributor capabilities, and local training capacity materially influence time-to-adoption. Consequently, manufacturers that combine robust clinical support, adaptable pricing models, and regional supply chain resilience are better positioned to capture sustained uptake across these varied markets.

Competitive landscape insights highlighting strategic behaviors, capability gaps, and partnership opportunities among device manufacturers and ecosystem partners

Leading companies continue to compete on a combination of technical differentiation, clinical evidence, and service-level guarantees. Product roadmaps increasingly emphasize modularity and anatomical customization to capture complex anatomies, while other manufacturers concentrate on low-profile delivery systems and simplified deployment to address high-volume elective programs. Strategic behaviors also include targeted acquisitions to fill capability gaps in branched or fenestrated technologies, as well as licensing arrangements and co-development agreements designed to accelerate time to market for specialized solutions.

Emerging entrants often leverage narrow innovation niches-improved fixation mechanisms, novel fabric technologies, or advanced imaging integration-to gain clinical footholds, but scaling those innovations requires robust clinical partnerships and distribution capabilities. Established players retain advantages in global regulatory experience, manufacturing scale, and installed clinical support networks, yet they face pressure to demonstrate post-market outcomes and cost-effectiveness. There is growing evidence of collaborative models where manufacturers, clinical centers, and payers co-design registries and long-term follow-up studies to validate real-world performance and support reimbursement discussions. Overall, the competitive dynamic rewards organizations that pair technical differentiation with operational excellence and credible long-term evidence commitments.

Actionable recommendations that industry leaders can implement to enhance resilience, accelerate adoption, and maximize clinical impact

Manufacturers should prioritize modular product platforms that can address a spectrum of anatomic challenges while enabling manufacturing efficiency and inventory rationalization. Investing in comprehensive clinical evidence generation, including prospective registries and pragmatic real-world studies, will strengthen value propositions with hospitals and payers and reduce barriers to adoption. Operationally, diversifying critical component suppliers and exploring regional manufacturing or contract manufacturing partnerships can reduce tariff and logistics exposure while improving responsiveness to local demand.

Commercial teams should design differentiated go-to-market approaches for hospitals versus ambulatory surgical centers, aligning training, inventory models, and post-procedural support accordingly. Strategic collaborations with high-volume clinical centers to build centers of excellence and targeted training curricula can shorten adoption curves. Finally, engaging early with health economics experts and payer stakeholders to build clear reimbursement narratives will be essential for securing formulary placement and unit uptake, particularly for higher-cost branched and fenestrated solutions that deliver demonstrable downstream value.

Research methodology and evidence synthesis approach used to evaluate clinical, commercial, and regulatory dimensions of aortic stent grafts

The analysis integrates a mixed-methods research design that synthesizes primary qualitative inputs with comprehensive secondary evidence. Primary engagement included structured interviews with clinicians, hospital procurement leaders, and device development experts to capture practice patterns, device preferences, and procurement sensitivities. These qualitative insights were triangulated with secondary sources including peer-reviewed clinical literature, public regulatory filings, device labeling, clinical trial registries, and institutional guidelines to validate technical claims and clinical performance narratives.

Data synthesis emphasized cross-validation across independent sources and the use of scenario analysis to assess the robustness of strategic conclusions under varying operational assumptions. Where available, post-market surveillance summaries and registry data were used to contextualize durability and safety profiles. The methodology also incorporated rigorous segmentation mapping to align device features with clinical use-cases and buyer archetypes. Throughout, the approach aimed to balance depth of clinical insight with practical commercial implications to deliver a usable framework for decision-making.

Conclusion synthesizing strategic implications for stakeholders across clinical, commercial, and operational domains

The aortic stent graft sector is advancing into a phase where technical complexity, evidence demands, and supply chain resilience jointly define competitive advantage. Success will hinge on the ability to deliver devices that match increasingly sophisticated anatomic requirements while simultaneously demonstrating real-world outcomes and cost-effectiveness. Organizations that integrate R&D advances with rigorous evidence programs and resilient operational strategies will be best positioned to meet clinician expectations and procurement demands.

Looking forward, the interplay between evolving clinical indications, tariff and trade pressures, and regional adoption heterogeneity will create both challenges and opportunities. Firms that adopt a disciplined approach to segmentation, prioritize high-impact clinical partnerships, and build flexible manufacturing and distribution models will be able to accelerate adoption across diverse care settings. The actionable recommendations provided here are intended to guide leaders in aligning product portfolios, evidence generation, and operational capabilities to capture the long-term value potential inherent in modern aortic therapies.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aortic Stent Grafts Market, by Aneurysm Location

• 8.1. Abdominal Aortic Aneurysm
• 8.2. Thoracic Aortic Aneurysm
• 8.3. Thoracoabdominal Aortic Aneurysm

9. Aortic Stent Grafts Market, by Graft Type

• 9.1. Branched Stent Graft
• 9.2. Fenestrated Stent Graft
• 9.3. Standard Stent Graft

10. Aortic Stent Grafts Market, by Configuration

• 10.1. Aorto-Uni-Iliac
• 10.2. Bifurcated
• 10.3. Cuff

11. Aortic Stent Grafts Market, by Deployment Mechanism

• 11.1. Balloon Expandable
• 11.2. Self Expanding

12. Aortic Stent Grafts Market, by End User

• 12.1. Ambulatory Surgical Centers
• 12.2. Hospitals

13. Aortic Stent Grafts Market, by Access Route

• 13.1. Iliac
• 13.2. Transfemoral

14. Aortic Stent Grafts Market, by Material

• 14.1. Expanded Polytetrafluoroethylene
• 14.2. Polyester

15. Aortic Stent Grafts Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Aortic Stent Grafts Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Aortic Stent Grafts Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. United States Aortic Stent Grafts Market

19. China Aortic Stent Grafts Market

20. Competitive Landscape

• 20.1. Market Concentration Analysis, 2025
  • 20.1.1. Concentration Ratio (CR)
  • 20.1.2. Herfindahl Hirschman Index (HHI)
• 20.2. Recent Developments & Impact Analysis, 2025
• 20.3. Product Portfolio Analysis, 2025
• 20.4. Benchmarking Analysis, 2025
• 20.5. Abbott Laboratories
• 20.6. Aortec Medical Technology Co., Ltd
• 20.7. Aptus Endosystems, Inc.
• 20.8. Artivion, Inc.
• 20.9. Becton, Dickinson and Company
• 20.10. Bentley InnoMed GmbH
• 20.11. Bolton Medical Inc.
• 20.12. Cardinal Health, Inc.
• 20.13. Cook Medical LLC
• 20.14. CryoLife, Inc.
• 20.15. Endologix, Inc.
• 20.16. Endospan Ltd
• 20.17. JOTEC GmbH
• 20.18. LifeTech Scientific Co., Ltd
• 20.19. Lombard Medical Ltd
• 20.20. Medtronic plc
• 20.21. Merit Medical Systems, Inc.
• 20.22. MicroPort Scientific Corporation
• 20.23. Terumo Corporation
• 20.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL AORTIC STENT GRAFTS MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL AORTIC STENT GRAFTS MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 13. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 14. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 15. CHINA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACIC AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL AORTIC ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL AORTIC ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY THORACOABDOMINAL AORTIC ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BRANCHED STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BRANCHED STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BRANCHED STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY FENESTRATED STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY FENESTRATED STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY FENESTRATED STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY STANDARD STENT GRAFT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY STANDARD STENT GRAFT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY STANDARD STENT GRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AORTO-UNI-ILIAC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AORTO-UNI-ILIAC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AORTO-UNI-ILIAC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BIFURCATED, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BIFURCATED, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BIFURCATED, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CUFF, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CUFF, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY CUFF, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ILIAC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ILIAC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY ILIAC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY TRANSFEMORAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY TRANSFEMORAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY TRANSFEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 61. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 62. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 63. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 64. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 65. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 66. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 67. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 68. AMERICAS AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 69. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 70. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 71. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 72. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 73. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 74. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 75. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 76. NORTH AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 77. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 78. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 79. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 80. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 81. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 82. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 83. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 84. LATIN AMERICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 91. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 92. EUROPE, MIDDLE EAST & AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 93. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 94. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 95. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 96. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 97. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 98. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 99. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 100. EUROPE AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 101. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 102. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 103. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 104. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 105. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 106. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 107. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 108. MIDDLE EAST AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 109. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 110. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 111. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 112. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 113. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 114. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 115. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 116. AFRICA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 117. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 118. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 119. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 120. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 121. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 122. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 123. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 124. ASIA-PACIFIC AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 125. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 126. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 127. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 128. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 129. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 130. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 131. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 132. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 133. ASEAN AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 134. GCC AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 135. GCC AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 136. GCC AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 137. GCC AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 138. GCC AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 139. GCC AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 140. GCC AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 141. GCC AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 142. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 143. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 144. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 145. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 146. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 147. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 148. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 149. EUROPEAN UNION AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 150. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 151. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 152. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 153. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 154. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 155. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 156. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 157. BRICS AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 158. G7 AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 159. G7 AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 160. G7 AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 161. G7 AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 162. G7 AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 163. G7 AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 164. G7 AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 165. G7 AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 166. NATO AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 167. NATO AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 168. NATO AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 169. NATO AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 170. NATO AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 171. NATO AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 172. NATO AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 173. NATO AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 174. GLOBAL AORTIC STENT GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 175. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 176. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 177. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 178. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 179. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 180. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 181. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 182. UNITED STATES AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 183. CHINA AORTIC STENT GRAFTS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 184. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY ANEURYSM LOCATION, 2018-2032 (USD MILLION)
• TABLE 185. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
• TABLE 186. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY CONFIGURATION, 2018-2032 (USD MILLION)
• TABLE 187. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY DEPLOYMENT MECHANISM, 2018-2032 (USD MILLION)
• TABLE 188. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 189. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY ACCESS ROUTE, 2018-2032 (USD MILLION)
• TABLE 190. CHINA AORTIC STENT GRAFTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)